Aidan Hollis is Professor of Economics at the University of Calgary, and President of Incentives for Global Health, a US-based NGO focused on the development of the Health Impact Fund and Green Impact Fund for Technology proposals.
Education and Training
Hollis studied at Cambridge University and the University of Toronto, where he obtained a PhD in economics. He has worked in the private sector (in banking) and in government (at the Canadian Competition Bureau).
Research Interests and Expertise
His research focuses on innovation and competition in pharmaceutical markets, and he has published over eighty peer-reviewed articles and two books in a range of fields of economics. He has provided expert reports and testimony in a variety of pharmaceutical-related cases in Federal, Appeals and Supreme Court cases in Canada, and has advised companies and governments. He served on the WHO Guideline Development Group on Antimicrobial Use in Food Animals and the Expert Advisory Group for the Global AMR R&D Hub. The current pricing model used by the Canadian provinces for generic drugs is based on his research. He has held, as Principal Investigator, grants totaling several million dollars from CIHR, SSHRC and ERC.